Alternative Splicing and Promoter Usage Generates an Intracellular Stromelysin 3 Isoform Directly Translated as an Active Matrix Metalloproteinase
Open Access
- 1 July 2002
- journal article
- Published by Elsevier BV
- Vol. 277 (28), 25527-25536
- https://doi.org/10.1074/jbc.m202494200
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and TribulationsScience, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Cysteine Array Matrix Metalloproteinase (CA-MMP)/MMP-23 Is a Type II Transmembrane Matrix Metalloproteinase Regulated by a Single Cleavage for Both Secretion and ActivationJournal of Biological Chemistry, 2000
- Demonstration in vivo that stromelysin-3 functions through its proteolytic activityOncogene, 2000
- Cloning and Characterization of Human MMP-23, a New Matrix Metalloproteinase Predominantly Expressed in Reproductive Tissues and Lacking Conserved Domains in Other Family MembersPublished by Elsevier BV ,1999
- In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell MalignancyThe Journal of cell biology, 1998
- Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3Journal of Biological Chemistry, 1997
- Furin-dependent intracellular activation of the human stromelysin-3 zymogenNature, 1995
- The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis.The Journal of cell biology, 1992
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990